Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
ACS Chemical Neuroscience|October 19, 2020
(E)-3-Furan-2-yl-N-p-tolyl-acrylamide and its Derivative DM489 Decrease Neuropathic Pain in Mice Predominantly by α7 Nicotinic Acetylcholine Receptor PotentiationHugo R Arias, Carla Ghelardini, Elena Lucarini, et al.Bioorganic & Medicinal Chemistry|December 19, 2012
New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR)Francesca Orlandi, Marcella Coronnello, Cristina Bellucci, et al.European Journal of Pharmacology|January 22, 2024
The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activationHugo R Arias, Deborah Rudin, Dustin J Hines, et al.Bioorganic & Medicinal Chemistry Letters|March 28, 2015
Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235Luca Guandalini, Maria Vittoria Martino, Lorenzo Di Cesare Mannelli, et al.Journal of Medicinal Chemistry|January 15, 2009
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitorsCecilia Martelli, Daniela Alderighi, Marcella Coronnello, et al.ACS Medicinal Chemistry Letters|April 19, 2019
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in TissuesMaria Novella Romanelli, Martina Del Lungo, Luca Guandalini, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 18, 2024
Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activationHugo R Arias, Laura Micheli, Deborah Rudin, et al.Journal of Medicinal Chemistry|November 26, 2009
Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structureSerena Scapecchi, Marta Nesi, Rosanna Matucci, et al.European Journal of Pharmacology|June 14, 2020
Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptorsRosanna Matucci, Cristina Bellucci, Maria Vittoria Martino, et al.ACS Chemical Neuroscience|May 1, 2026
Activity of Nonhallucinogenic Ibogalogs on Chemotherapy-Induced Peripheral Neuropathic Pain in MiceJason Younkin, Eda Koseli, Belle Buzzi, et al.Pageof 8